Moderna withdraws application for US approval of combined flu-Covid shot

After talks with Food and Drug Administration, company plans to resubmit vaccine application later this year

Moderna said on Wednesday it had withdrawn an application seeking approval for its flu and Covid combination vaccine candidate after discussions with the US Food and Drug Administration.

The company said it would resubmit the application later this year with vaccine efficacy data from a late-stage trial of its experimental seasonal influenza vaccine, which it expects to report this summer.